Male Breast Cancer Survivor Spreads Awareness: 'Men Have Breasts, Too!'

Video

Sam Rivera, a 47-year male breast cancer survivor, sat down with CURE at the 36th Annual Miami Breast Cancer Conference to discuss the importance of communicating family health history, to advise men to be proactive about their health and to share his positive experience with the Male Breast Cancer Coalition.

Sam Rivera, a 47-year male breast cancer survivor, sat down with CURE at the 36th Annual Miami Breast Cancer Conference to discuss the importance of communicating family health history, to advise men to be proactive about their health and to share his positive experience with the Male Breast Cancer Coalition.

Rivera received a diagnosis of male breast cancer in September 1971 at the age of 18. After basic training in the military, Rivera’s doctor noticed a bloody discharge from his left nipple during a routine examination. Rivera explained how he was shocked, in denial and embarrassed to find out he had a “women’s disease.”

“I should have known better, because my aunt passed away of breast cancer a few months earlier, so the disease was in my family.” Several members of Rivera’s family have also had breast cancer, including his grandfather who lived to the age of 110, an aunt and a niece. “I now know that this disease doesn’t discriminate.”

Rivera urged other men with breast cancer to not be ashamed to talk about their disease, to help other men to identify with their disease, seek support and be proactive about their health.

Related Videos
Jessica McDade, B.S.N., RN, OCN, in an interview with CURE
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE
Dr. Barzi in an interview with CURE
Related Content